Torrent Pharmaceuticals Limited has informed the Exchange about Investor Presentation
24th January, 2025
The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1st Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Code: 500420)
The Manager – Listing Dept., National Stock Exchange of India Ltd., Exchange Plaza, 5th Floor, Plot No. C/1, G. Block, Bandra - Kurla Complex, Bandra (E), Mumbai – 400 051 (NSE Scrip Code: TORNTPHARM)
Dear Sir,
Sub.: Presentation to analysts on unaudited Consolidated Financial Results for the quarter
and nine months ended 31st December, 2024
The Presentation on unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2024 to be made to analysts is enclosed for your records.
Thanking you,
Yours sincerely,
For TORRENT PHARMACEUTICALS LIMITED
CHINTAN M. TRIVEDI COMPANY SECRETARY
Encl : A/a
___________________________________________________________________________________ TORRENT PHARMACEUTICALS LIMITED CIN: L24230GJ1972PLC002126 Reg.Office : Torrent House, Off Ashram Road, Ahmedabad- 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100, www.torrentpharma.com, Email : InvestorServices@TorrentPharma.com
Q3 FY 2024-25
Revenues: Summary
1
Revenue: Summary
Revenues (Rs cr)
Q3 FY25
Q3 FY24
India
United States
Germany
Brazil
Others
Total
1581
1415
271
282
291
384
274
270
312
461
2809
2732
Gr%
12%
‐1%
4%
‐7%
‐16%
3%
2
Revenue: Summary
Revenues (Rs cr)
9M FY25
9M FY24
India
United States
Germany
Brazil
Others
Total
4848
798
853
750
1308
8557
4286
815
795
754
1333
7983
Gr%
13%
‐2%
7%
‐1%
‐2%
7%
3